- LIVE QUOTES
- LEARN
- HELP
More from Webull
Our Partners
Wall Street JournalEN
V
VXRT
Vaxart Inc
0.43
-0.02-4.92%After Hours: 0.4200 -0.01 -1.22%18:15 04/29 EDT
OPEN/PREV CLOSE0.4700/0.4472
TODAY RANGE0.4250-0.4750
VOL2.27M
MARKET CAP97.03M
52 WEEK RANGE0.2850-1.070
AVG VOL (3M)1.90M
% TURNOVER0.99%
TURNOVER--
P/E (TTM)-1.2838
% RANGE11.18%
EPS(TTM)-0.3312
P/E(FORWARD)-1.5748
P/B1.644
BVPS0.2587
DIVIDEND--
P/S3.375
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP95.91M
SHARES OUTSTANDING228.21M
NEXT EARNINGS05/12-05/16
FREE FLOAT225.55M
LOT SIZE1
EX-DIV DATE02/14/2018
News
Press Releases
Financial Reports
Profile
TipRanks·04/15 17:15
Roth says BARDA stopping funding for GeoVax COVID trial similar to peers
Dow Jones·03/27 17:29
Vaxart Price Target Cut to $2.00/Share From $2.50 by B. Riley Securities
Dow Jones·03/27 17:29
Vaxart Is Maintained at Buy by B. Riley Securities
Benzinga·03/27 17:19
B. Riley Securities Maintains Buy on Vaxart, Lowers Price Target to $2
TipRanks·03/27 13:15
Vaxart price target lowered to $2 from $2.50 at B. Riley
Reuters·03/27 12:00
VAXART, INC. REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)
TipRanks·03/22 00:06
Vaxart’s Earnings Call: Revenue Soars Amid COVID-19 Hurdles
TipRanks·03/21 03:55
Vaxart Reports 2024 Financial Results and Vaccine Progress
NASDAQ·03/20 21:15
VAXART, INC. (VXRT) Reports Q4 Loss, Lags Revenue Estimates
Dow Jones·03/20 20:07
*Vaxart Sees Funding Sufficient Into 4Q >VXRT
Dow Jones·03/20 20:06
*Vaxart 2024 Loss/Shr 33c >VXRT
Dow Jones·03/20 20:06
*Vaxart 2024 Rev $28.7M >VXRT
Reuters·03/20 20:01
VAXART INC - IMPLEMENTS 10% WORKFORCE REDUCTION
Reuters·03/20 20:01
VAXART PROVIDES BUSINESS UPDATE AND REPORTS FULL YEAR 2024 FINANCIAL RESULTS
Same Industry
Name/Symbol
Change%
Price